Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Regeneron acquires 23andMe for $256 million following its bankruptcy. The deal includes DNA data access, raising privacy ...

Share on Facebook Share on Twitter Jaelen Johnston continues to prove that it’s not how you start, it’s how you finish. On ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Dow Jones Top Company Headlines at 7 AM ET: Home Depot Backs Guidance as Sales Top Estimates | Honda ... The company's CEO said customers continued to spend on smaller home-improvement projects. The ...

Dow Jones Top Company Headlines at 5 AM ET: Chinese Battery Giant CATL’s Shares Surge on Hong Kong Debut | Honda ... The listing comes as risk appetite has returned to global markets as trade ...

Regeneron Pharmaceuticals said in a press release yesterday that it would acquire 23andMe’s Personal Genome Service (PGS), ...

The California Public Utilities Commission has given the green light to Waymo to allow its autonomous vehicle fleet in nearly ...

The measure given final approval by the state Senate and sent to Gov. Greg Abbott is dubbed the “The Uvalde Strong Act” and ...